Logo image of B2I.OL

B2 IMPACT ASA (B2I.OL) Stock Fundamental Analysis

OSL:B2I - Euronext Oslo - NO0010633951 - Common Stock - Currency: NOK

11.68  +0.32 (+2.82%)

Fundamental Rating

6

Overall B2I gets a fundamental rating of 6 out of 10. We evaluated B2I against 8 industry peers in the Consumer Finance industry. While B2I has a great health rating, its profitability is only average at the moment. B2I scores decently on growth, while it is valued quite cheap. This could make an interesting combination. Finally B2I also has an excellent dividend rating. These ratings could make B2I a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

B2I had positive earnings in the past year.
In the past year B2I had a positive cash flow from operations.
Each year in the past 5 years B2I has been profitable.
Each year in the past 5 years B2I had a positive operating cash flow.
B2I.OL Yearly Net Income VS EBIT VS OCF VS FCFB2I.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

B2I's Return On Assets of 1.63% is fine compared to the rest of the industry. B2I outperforms 62.50% of its industry peers.
B2I has a Return On Equity of 4.93%. This is in the lower half of the industry: B2I underperforms 62.50% of its industry peers.
The Return On Invested Capital of B2I (6.69%) is better than 87.50% of its industry peers.
B2I had an Average Return On Invested Capital over the past 3 years of 7.68%. This is above the industry average of 5.57%.
Industry RankSector Rank
ROA 1.63%
ROE 4.93%
ROIC 6.69%
ROA(3y)1.9%
ROA(5y)2.25%
ROE(3y)5.89%
ROE(5y)7.14%
ROIC(3y)7.68%
ROIC(5y)7.31%
B2I.OL Yearly ROA, ROE, ROICB2I.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

B2I has a Profit Margin (7.77%) which is in line with its industry peers.
In the last couple of years the Profit Margin of B2I has grown nicely.
Looking at the Operating Margin, with a value of 38.81%, B2I belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of B2I has grown nicely.
B2I has a worse Gross Margin (54.88%) than 62.50% of its industry peers.
B2I's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.81%
PM (TTM) 7.77%
GM 54.88%
OM growth 3Y-0.73%
OM growth 5Y3.42%
PM growth 3Y-25.46%
PM growth 5Y15.37%
GM growth 3Y-1.72%
GM growth 5Y0.89%
B2I.OL Yearly Profit, Operating, Gross MarginsB2I.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so B2I is destroying value.
Compared to 1 year ago, B2I has about the same amount of shares outstanding.
B2I has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, B2I has an improved debt to assets ratio.
B2I.OL Yearly Shares OutstandingB2I.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
B2I.OL Yearly Total Debt VS Total AssetsB2I.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

The Debt to FCF ratio of B2I is 2.63, which is a good value as it means it would take B2I, 2.63 years of fcf income to pay off all of its debts.
B2I's Debt to FCF ratio of 2.63 is amongst the best of the industry. B2I outperforms 100.00% of its industry peers.
B2I has a Debt/Equity ratio of 1.74. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of B2I (1.74) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 2.63
Altman-Z N/A
ROIC/WACC0.83
WACC8.06%
B2I.OL Yearly LT Debt VS Equity VS FCFB2I.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

B2I has a Current Ratio of 2.09. This indicates that B2I is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.09, B2I belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Quick Ratio of 2.09 indicates that B2I has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.09, B2I belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
B2I.OL Yearly Current Assets VS Current LiabilitesB2I.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for B2I have decreased strongly by -20.21% in the last year.
B2I shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.67% yearly.
Looking at the last year, B2I shows a decrease in Revenue. The Revenue has decreased by -7.78% in the last year.
B2I shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.89% yearly.
EPS 1Y (TTM)-20.21%
EPS 3Y-18.59%
EPS 5Y22.67%
EPS Q2Q%-70.59%
Revenue 1Y (TTM)-7.78%
Revenue growth 3Y5.29%
Revenue growth 5Y4.89%
Sales Q2Q%-19.87%

3.2 Future

The Earnings Per Share is expected to grow by 38.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, B2I will show a small growth in Revenue. The Revenue will grow by 0.56% on average per year.
EPS Next Y104.02%
EPS Next 2Y46.79%
EPS Next 3Y38.08%
EPS Next 5YN/A
Revenue Next Year-4.06%
Revenue Next 2Y-0.2%
Revenue Next 3Y0.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
B2I.OL Yearly Revenue VS EstimatesB2I.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
B2I.OL Yearly EPS VS EstimatesB2I.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.57, the valuation of B2I can be described as correct.
Based on the Price/Earnings ratio, B2I is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
B2I is valuated rather cheaply when we compare the Price/Earnings ratio to 27.85, which is the current average of the S&P500 Index.
B2I is valuated cheaply with a Price/Forward Earnings ratio of 7.63.
Based on the Price/Forward Earnings ratio, B2I is valued a bit cheaper than 75.00% of the companies in the same industry.
B2I's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.77.
Industry RankSector Rank
PE 15.57
Fwd PE 7.63
B2I.OL Price Earnings VS Forward Price EarningsB2I.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, B2I is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.16
EV/EBITDA N/A
B2I.OL Per share dataB2I.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

B2I's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
B2I has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as B2I's earnings are expected to grow with 38.08% in the coming years.
PEG (NY)0.15
PEG (5Y)0.69
EPS Next 2Y46.79%
EPS Next 3Y38.08%

7

5. Dividend

5.1 Amount

B2I has a Yearly Dividend Yield of 13.91%, which is a nice return.
B2I's Dividend Yield is rather good when compared to the industry average which is at 3.64. B2I pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, B2I pays a better dividend.
Industry RankSector Rank
Dividend Yield 13.91%

5.2 History

The dividend of B2I is nicely growing with an annual growth rate of 32.90%!
Dividend Growth(5Y)32.9%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

172.92% of the earnings are spent on dividend by B2I. This is not a sustainable payout ratio.
B2I's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP172.92%
EPS Next 2Y46.79%
EPS Next 3Y38.08%
B2I.OL Yearly Income VS Free CF VS DividendB2I.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
B2I.OL Dividend Payout.B2I.OL Dividend Payout, showing the Payout Ratio.B2I.OL Dividend Payout.PayoutRetained Earnings

B2 IMPACT ASA

OSL:B2I (5/2/2025, 12:21:51 PM)

11.68

+0.32 (+2.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-15 2025-05-15
Inst Owners18.98%
Inst Owner ChangeN/A
Ins Owners1.45%
Ins Owner ChangeN/A
Market Cap4.30B
Analysts82.22
Price Target12.72 (8.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 13.91%
Yearly Dividend1.3
Dividend Growth(5Y)32.9%
DP172.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-167.72%
Min EPS beat(2)-252.32%
Max EPS beat(2)-83.12%
EPS beat(4)1
Avg EPS beat(4)-70.73%
Min EPS beat(4)-252.32%
Max EPS beat(4)67.16%
EPS beat(8)3
Avg EPS beat(8)-34.69%
EPS beat(12)4
Avg EPS beat(12)-31.94%
EPS beat(16)7
Avg EPS beat(16)764.39%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-6.16%
Max Revenue beat(2)1.08%
Revenue beat(4)2
Avg Revenue beat(4)0.58%
Min Revenue beat(4)-8.75%
Max Revenue beat(4)16.17%
Revenue beat(8)5
Avg Revenue beat(8)3.53%
Revenue beat(12)9
Avg Revenue beat(12)3.28%
Revenue beat(16)10
Avg Revenue beat(16)1.59%
PT rev (1m)0%
PT rev (3m)8.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.89%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)9.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-2.22%
Valuation
Industry RankSector Rank
PE 15.57
Fwd PE 7.63
P/S 1.21
P/FCF 1.16
P/OCF 1.15
P/B 0.77
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)0.75
EY6.42%
EPS(NY)1.53
Fwd EY13.1%
FCF(TTM)10.11
FCFY86.52%
OCF(TTM)10.2
OCFY87.31%
SpS9.68
BVpS15.24
TBVpS13.05
PEG (NY)0.15
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 4.93%
ROCE 8.76%
ROIC 6.69%
ROICexc 7.59%
ROICexgc 8.05%
OM 38.81%
PM (TTM) 7.77%
GM 54.88%
FCFM 104.43%
ROA(3y)1.9%
ROA(5y)2.25%
ROE(3y)5.89%
ROE(5y)7.14%
ROIC(3y)7.68%
ROIC(5y)7.31%
ROICexc(3y)8.54%
ROICexc(5y)8.17%
ROICexgc(3y)9.12%
ROICexgc(5y)8.78%
ROCE(3y)10.04%
ROCE(5y)9.56%
ROICexcg growth 3Y-5.59%
ROICexcg growth 5Y8.24%
ROICexc growth 3Y-4.59%
ROICexc growth 5Y8.45%
OM growth 3Y-0.73%
OM growth 5Y3.42%
PM growth 3Y-25.46%
PM growth 5Y15.37%
GM growth 3Y-1.72%
GM growth 5Y0.89%
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 2.63
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.95%
Interest Coverage 1.57
Cash Conversion N/A
Profit Quality 1344.4%
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z N/A
F-Score5
WACC8.06%
ROIC/WACC0.83
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.16%
Cap/Sales(5y)1.31%
Profit Quality(3y)1154.43%
Profit Quality(5y)1017%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.21%
EPS 3Y-18.59%
EPS 5Y22.67%
EPS Q2Q%-70.59%
EPS Next Y104.02%
EPS Next 2Y46.79%
EPS Next 3Y38.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.78%
Revenue growth 3Y5.29%
Revenue growth 5Y4.89%
Sales Q2Q%-19.87%
Revenue Next Year-4.06%
Revenue Next 2Y-0.2%
Revenue Next 3Y0.56%
Revenue Next 5YN/A
EBIT growth 1Y4.22%
EBIT growth 3Y4.52%
EBIT growth 5Y8.48%
EBIT Next Year-2.12%
EBIT Next 3Y1.33%
EBIT Next 5YN/A
FCF growth 1Y-11.82%
FCF growth 3Y2.53%
FCF growth 5Y0.92%
OCF growth 1Y-12.4%
OCF growth 3Y2.35%
OCF growth 5Y0.81%